Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular corticosteroid injection vs arthrocentesis for temporomandibular joint arthritis
2023-509114-11-00Phase 4Authorised
- Sponsor
- Region Västra Götaland
- Start
- Mar 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of methylprednisolone in temporomandibular arthritis (2 arms), sponsored by Region Västra Götaland. Planned start Mar 2024; status: authorised.
02
Drugs
methylprednisolone
03
Conditions
temporomandibular arthritis
Beyond the preview
Go deeper on 2023-509114-11-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-509114-11-00.